SMR vs XE: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
XE is the larger of the two ($4.69B market cap): the incumbent the market prices for continued execution (-32.34x forward earnings). SMR is the smaller challenger ($2.91B), priced similarly on forward earnings (-11.75x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
SMR vs XE: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | SMR | XE | What it tells you |
|---|---|---|---|
| Market cap | $2.91B | $4.69B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | -11.75 | -32.34 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Price vs 52-week range | 2% of range | 13% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
Before you buy: how SMR and XE affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. SMR and XE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined SMR and XE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does NuScale Power (SMR) do?
NuScale Power (SMR) is a developer of small modular nuclear reactors (SMRs), aiming to commercialize compact, factory-built reactor modules as an alternative to large conventional nuclear plants. Its flagship design is a pressurized-water reactor module that can be deployed individually or in groups to scale capacity, and it is among the few SMR designs to receive design certification or approval from the US Nuclear Regulatory Commission, a notable regulatory milestone. The pitch for SMRs is safer, more standardized, lower-upfront-cost nuclear power that can provide carbon-free, always-on baseload electricity, including for data centers and industrial users with growing power needs. NuScale is majority-affiliated with Fluor, an engineering and construction firm, and works with utility and government partners. The company is early-stage and largely pre-revenue from operating plants: it has not yet brought a commercial SMR online, and an earlier flagship deployment project was cancelled, underscoring cost and timeline challenges. Headquartered in Portland, Oregon, NuScale is a speculative, long-horizon bet on whether small modular reactors achieve commercial scale and cost-competitiveness.
What does X-Energy (XE) do?
X-Energy, Inc. designs advanced small modular nuclear reactors and manufactures the fuel that powers them. Its flagship Xe-100 is a high-temperature gas-cooled reactor sized at roughly 80 megawatts of electric output (200 megawatts thermal), aimed at industrial sites and data centers, and its TRISO-X fuel business makes the coated-particle fuel the reactors run on. Founded in 2009 and headquartered in Rockville, Maryland, the company is developing its first Xe-100 plant at Dow's Seadrift site on the Texas Gulf Coast under the U.S. Department of Energy's Advanced Reactor Demonstration Program, and has offtake and partnership arrangements tied to Amazon, Dow, Centrica, Talen Energy, and utilities in Kentucky.
SMR vs XE: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- SMR drivers: Regulatory progress and design certification; Demand for carbon-free baseload and data-center power.
- XE drivers: AI and data-center power demand; Government backing and the Dow demonstration.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: NuScale is early-stage and largely pre-revenue, with ongoing operating losses, so it depends on its cash and periodic capital raises that can dilute shareholders. For XE, x-Energy is pre-commercial, so it generates large losses and has no proven history of building and operating reactors at scale.
SMR or XE: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick SMR if you believe its drivers more; XE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the SMR and XE guides.
SMR vs XE: the full fundamentals
SMR. NuScale cannot be valued on earnings because it has little operating revenue and runs losses. The market prices it on the option value of small modular reactors reaching commercial deployment years out, so the stock is very volatile and moves on regulatory milestones, project announcements, government policy, and energy and AI-power sentiment. Figures are approximate and change frequently; verify current cash, burn rate, and share count, which dilution can move materially.
XE. As of July 2026, X-Energy trades at a very high multiple of its modest revenue because the market is pricing future reactor deployments rather than current results. Q1 2026 revenue and grant income roughly doubled year over year to about $43 million, but losses remain large as the company invests in licensing, fuel facilities, and its first plant. The April 2026 IPO added roughly $1.1 billion of cash, funding operations toward its demonstration milestones.
Headline figures (approximate, early 2026): SMR shows revenue (ttm) ~minimal operating revenue (pre-commercial; verify), profitability Unprofitable; ongoing operating losses, cash burn ~tens of millions-plus per year (verify latest), cash position Supported by capital raises; varies (verify current); XE shows share price ~$16.50, market cap ~$6.7B, revenue + grant income (ttm) ~$117M, 2025 revenue ~$94M.
The bottom line: SMR vs XE
SMR and XE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined SMR and XE exposure against your real portfolio. It is not an investment adviser.
Wondering how SMR or XE fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in NuScale Power with AI
Connect the broker you already use and ask Walnut's AI how SMR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between SMR and XE?
+
NuScale Power (SMR) is a developer of small modular nuclear reactors (SMRs), aiming to commercialize compact, factory-built reactor modules as an alternative to large conventional nuclear plants. X-Energy, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is SMR or XE the better stock?
+
Neither is universally better. XE is the larger incumbent; SMR is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, SMR or XE?
+
On forward P/E (as of August 2026), SMR trades at -11.75x and XE at -32.34x, so XE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both SMR and XE?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of SMR vs XE?
+
SMR: NuScale is early-stage and largely pre-revenue, with ongoing operating losses, so it depends on its cash and periodic capital raises that can dilute shareholders. It has not yet brought a commercial SMR online, and an earlier flagship deployment project was cancelled over cost concerns, a stark reminder that SMR economics are unproven at scale. Nuclear projects face long timelines, heavy regulation, financing hurdles, and public and political sensitivity. Competition includes other SMR developers and alternative clean-power sources. The stock is highly volatile and trades on milestone news, government policy, and energy and AI-power sentiment. An investment could lose substantial value if deployments do not materialize. XE: X-Energy is pre-commercial, so it generates large losses and has no proven history of building and operating reactors at scale. Trailing revenue near $117 million against a market cap of roughly $6.7 billion means the valuation is priced for deployments that are years away and not yet certain. Nuclear projects face long regulatory timelines, potential cost overruns, and construction delays, and the Xe-100 still needs NRC licensing and first-plant completion. Much of the pipeline consists of studies, offtake agreements, and memorandums rather than firm binding orders, and the company depends on continued government support and capital markets access. A shift in policy, a project setback, or dilution from future capital raises could weigh heavily on the shares.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell SMR or XE; figures are approximate and dated (as of August 2026). Verify current data before investing.